James B. McNally, SVP, Marketing & Business Development at GenMark Diagnostics, Inc. (GNMK), sold 848 shares at $5.13 ($4K) on 2018-02-02, disclosed to the SEC on 2018-02-06.
Open-market sale of $4k GNMK by SVP, Marketing & Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GNMK | SELL | 2019-11-01 | $10K | — | Filing → |
| GNMK | SELL | 2019-08-30 | $14K | — | Filing → |
| GNMK | SELL | 2019-08-08 | $6K | — | Filing → |